AI assistant
Sending…
ANGIODYNAMICS INC — Director's Dealing 2016
Jul 29, 2016
32939_dirs_2016-07-29_5c0990df-e7fb-4a8a-ab81-0037ee21f1e1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2016-07-27
Reporting Person: Gould Kevin J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-07-27 | Common Stock | A | 5063 | — | Acquired | 32088 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-07-27 | Non-Qualified Stock Option (right to buy) | $16.59 | A | 5945 | Acquired | 2023-07-27 | Common Stock (5945) | Direct |
Footnotes
F1: The acquisition of 5,063 shares of common stock represents 5,063 restricted stock units, each of which represents a contingent right to receive one share of AngioDynamics, Inc. common stock. The restricted stock units vest in three equal installments beginning on 07/27/2017.
F2: Options for 33 1/3% of the shares are each exercisable on 07/27/2017, 07/27/2018 and 07/27/2019, respectively.
More from ANGIODYNAMICS INC
Regulatory Filings
2026
Apr 23
Interim / Quarterly Report
2026
Apr 2
Regulatory Filings
2026
Apr 2
Major Shareholding Notification
2026
Mar 26
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 10
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Jan 14
Major Shareholding Notification
2026
Jan 8
Regulatory Filings
2026
Jan 6